These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30878827)

  • 1. Evaluation of synthetic substituted 1,2-dioxanes as novel agents against human leishmaniasis.
    Ortalli M; Varani S; Rosso C; Quintavalla A; Lombardo M; Trombini C
    Eur J Med Chem; 2019 May; 170():126-140. PubMed ID: 30878827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Pharmacophoric Role of the O-O Bond in Synthetic Antileishmanial Compounds: Comparison between 1,2-Dioxanes and Tetrahydropyrans.
    Ortalli M; Varani S; Cimato G; Veronesi R; Quintavalla A; Lombardo M; Monari M; Trombini C
    J Med Chem; 2020 Nov; 63(21):13140-13158. PubMed ID: 33091297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of lansine analogues as antileishmanial agents.
    Pieroni M; Girmay S; Sun D; Sahu R; Tekwani BL; Tan GT
    ChemMedChem; 2012 Nov; 7(11):1895-900. PubMed ID: 22987791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel steroid derivatives: synthesis, antileishmanial activity, mechanism of action, and in silico physicochemical and pharmacokinetics studies.
    da Trindade Granato J; Dos Santos JA; Calixto SL; Prado da Silva N; da Silva Martins J; da Silva AD; Coimbra ES
    Biomed Pharmacother; 2018 Oct; 106():1082-1090. PubMed ID: 30119174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinones against Leishmania (L.) infantum: biological activity and structure-activity relationships.
    Pinto EG; Santos IO; Schmidt TJ; Borborema SE; Ferreira VF; Rocha DR; Tempone AG
    PLoS One; 2014; 9(8):e105127. PubMed ID: 25171058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of chalcones as potential antileishmanial agents.
    Gupta S; Shivahare R; Korthikunta V; Singh R; Gupta S; Tadigoppula N
    Eur J Med Chem; 2014 Jun; 81():359-66. PubMed ID: 24858541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Catechol Derivatives of Arylimidamides as Antileishmanial Agents.
    Rezaei F; Saghaie L; Sabet R; Fassihi A; Hatam G
    Chem Biodivers; 2018 Oct; 15(10):e1800228. PubMed ID: 29999602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
    Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
    Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracts of Artemisia annua leaves and seeds mediate programmed cell death in Leishmania donovani.
    Islamuddin M; Farooque A; Dwarakanath BS; Sahal D; Afrin F
    J Med Microbiol; 2012 Dec; 61(Pt 12):1709-1718. PubMed ID: 22956747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antichagasic, Leishmanicidal, and Trichomonacidal Activity of 2-Benzyl-5-nitroindazole-Derived Amines.
    Fonseca-Berzal C; Ibáñez-Escribano A; Vela N; Cumella J; Nogal-Ruiz JJ; Escario JA; da Silva PB; Batista MM; Soeiro MNC; Sifontes-Rodríguez S; Meneses-Marcel A; Gómez-Barrio A; Arán VJ
    ChemMedChem; 2018 Jun; 13(12):1246-1259. PubMed ID: 29624912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antileishmanial activity and iron superoxide dismutase inhibition of arylamine Mannich base derivatives.
    Martin-Montes A; Santivañez-Veliz M; Moreno-Viguri E; Martín-Escolano R; Jiménez-Montes C; Lopez-Gonzalez C; Marín C; Sanmartín C; Gutiérrez Sánchez R; Sánchez-Moreno M; Pérez-Silanes S
    Parasitology; 2017 Nov; 144(13):1783-1790. PubMed ID: 28789716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents.
    Tiwari A; Kumar S; Shivahare R; Kant P; Gupta S; Suryawanshi SN
    Bioorg Med Chem Lett; 2015 Jan; 25(2):410-3. PubMed ID: 25475205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Biological Activity, and Mechanism of Action of 2-Pyrazyl and Pyridylhydrazone Derivatives, New Classes of Antileishmanial Agents.
    Coimbra ES; Antinarelli LMR; de A Crispi M; Nogueira TCM; Pinheiro AC; de Souza MVN
    ChemMedChem; 2018 Jul; 13(14):1387-1394. PubMed ID: 29790287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmanicidal, antiproteolytic, and mutagenic evaluation of alkyltriazoles and alkylphosphocholines.
    Gontijo VS; Espuri PF; Alves RB; de Camargos LF; Santos FV; de Souza Judice WA; Marques MJ; Freitas RP
    Eur J Med Chem; 2015 Aug; 101():24-33. PubMed ID: 26112378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive review of chalcone derivatives as antileishmanial agents.
    de Mello MVP; Abrahim-Vieira BA; Domingos TFS; de Jesus JB; de Sousa ACC; Rodrigues CR; Souza AMT
    Eur J Med Chem; 2018 Apr; 150():920-929. PubMed ID: 29602038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid heteropolysaccharides with potent antileishmanial effects.
    Kangussu-Marcolino MM; do Rosário MM; Noseda MD; Duarte ME; Ducatti DR; Cassolato JE; Iacomini M; Martinez GR; Rocha ME; Cadena SM; Noleto GR
    Int J Biol Macromol; 2015 Nov; 81():165-70. PubMed ID: 26162246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of cytotoxicity and leishmanicidal activity of phthalimido-thiazole derivatives.
    Aliança ASDS; Oliveira AR; Feitosa APS; Ribeiro KRC; de Castro MCAB; Leite ACL; Alves LC; Brayner FA
    Eur J Pharm Sci; 2017 Jul; 105():1-10. PubMed ID: 28478133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-silico Leishmania target selectivity of antiparasitic terpenoids.
    Ogungbe IV; Setzer WN
    Molecules; 2013 Jul; 18(7):7761-847. PubMed ID: 23823876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fishing for anti-leishmania drugs: principles and problems.
    Handman E; Kedzierski L; Uboldi AD; Goding JW
    Adv Exp Med Biol; 2008; 625():48-60. PubMed ID: 18365658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragment-Based Phenotypic Lead Discovery: Cell-Based Assay to Target Leishmaniasis.
    Ayotte Y; Bilodeau F; Descoteaux A; LaPlante SR
    ChemMedChem; 2018 Jul; 13(14):1377-1386. PubMed ID: 29722149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.